The Effect of Green Tea Consumption on Prostate Cancer Risk and Progression: A Systematic Review

References

• World Cancer Research Fund/American Institute for Cancer Research: Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC, 2007.
   Google Scholar
• Faezah A, Mehdi KP, Mahsa J, and Bahram R: Fruit and vegetables intake in relation to prostate cancer in Iranian Men: a case-control study. Asian Pac J Cancer Prev 15, 5317–5324, 2014. doi: 10.7314/APJCP.2014.15.13.5223
   PubMedGoogle Scholar
• Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al.: Cancer Statistics, 2009. CA: Cancer J Clin 59, 225–249, 2009. doi: 10.3322/caac.20006
   PubMed Web of Science ®Google Scholar
• Tombal B: Over- and underdiagnosis of prostate cancer: the dangers. Eur Urol Suppl 5, 511–513, 2006. doi: http://dx.doi.org/10.1016/j.eursup.2006.02.019
   Web of Science ®Google Scholar
• Pelzer AE, Colleselli D, Bektic J, Schaefer G, Ongarello S, et al.: Over-diagnosis and under-diagnosis of screen- vs non-screen-detected prostate cancers with in men with prostate-specific antigen levels of 2.0–10.0 ng/mL. BJU Int 101, 1223–1226, 2008. doi: 10.1111/j.1464-410X.2007.07367.x
   PubMed Web of Science ®Google Scholar
• Haas GP, Delongchamps N, Brawley OW, Wang CY, and de la Roza G: The worldwide epidemiology of prostate cancer: perspectives from autopsy studies. Can J Urol 15, 3866–3871, 2008.
   PubMed Web of Science ®Google Scholar
• Syed DN, Khan N, Afaq F, and Mukhtar H: Chemoprevention of prostate cancer through dietary agents: progress and promise. Cancer Epidemiol Biomarkers Prev 16, 2193–2203, 2007. doi: 10.1158/1055-9965.epi-06-0942
   PubMed Web of Science ®Google Scholar
• Yang C, Chen L, Lee M, Balentine D, Kuo M, et al.: Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol Biomarkers Prev 7, 351–354, 1998.
   PubMed Web of Science ®Google Scholar
• Adhami VM and Mukhtar H: Polyphenols from green tea and pomegranate for prevention of prostate cancer. Free Rad Res 40, 1095–1104, 2006.
   PubMed Web of Science ®Google Scholar
• Brown M: Green tea (Camellia sinensis) extract and its possible role in the prevention of cancer. Altern Med Rev 4, 360–370, 1999.
   PubMedGoogle Scholar
• Nakachi K, Matsuyama S, Miyake S, Suganuma M, and Imai K: Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. BioFactors 13, 49–54, 2000. doi: 10.1002/biof.5520130109
   PubMed Web of Science ®Google Scholar
• Béliveau R and Gingras D: Green tea: prevention and treatment of cancer by nutraceuticals. Lancet 364, 1021–1022, 2004. doi: http://dx.doi.org/10.1016/S0140-6736(04)17076-1
   PubMed Web of Science ®Google Scholar
• Mandair D, Rossi RE, Pericleous M, Whyand T, and Caplin ME: Prostate cancer and the influence of dietary factors and supplements: a systematic review. Nutr Metab 11, 30, 2014. doi: 10.1186/1743-7075-11-30
   Google Scholar
• Lin YW, Hu ZH, Wang X, Mao QQ, Qin J, et al.: Tea consumption and prostate cancer: an updated meta-analysis. World J Surg Oncol 12, 38, 2014. doi: 10.1186/1477-7819-12-38
   PubMed Web of Science ®Google Scholar
• Zheng J, Yang B, Huang T, Yu Y, Yang J, et al.: Green tea and black tea consumption and prostate cancer risk: an exploratory meta-analysis of observational studies. Nutr Cancer 63, 663–672, 2011. doi: 10.1080/01635581.2011.570895
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, et al.: The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62, e1–34, 2009. doi: http://dx.doi.org/10.1016/j.jclinepi.2009.06.006
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, et al.: The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. Br Med J 343, d5928, 2011. doi: 10.1136/bmj.d5928
   PubMed Web of Science ®Google Scholar
• Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, et al.: Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clin Trials 17, 1–12, 1996.
   PubMedGoogle Scholar
• Wells GA, Shea B, O'Connell D, Peterson J, Welch V, et al.: The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta-analyses, 2011; [cited 2016 Jan 25]. Available from http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
   Google Scholar
• Wilkinson S, Farrelly S, Low J, Chakraborty A, Williams R, et al.: The use of complementary therapy by men with prostate cancer in the UK. Eur J Cancer Care (Engl) 17, 492–499, 2008. doi: 10.1111/j.1365-2354.2007.00904.x
   PubMed Web of Science ®Google Scholar
• Wang P, Aronson WJ, Huang M, Zhang Y, Lee RP, et al.: Green tea polyphenols and metabolites in prostatectomy tissue: implications for cancer prevention. Cancer Prev Res (Phila) 3, 985–993, 2010. doi: 10.1158/1940-6207.capr-09-0210
   PubMed Web of Science ®Google Scholar
• Henning SM, Aronson W, Niu Y, Conde F, Lee NH, et al.: Tea polyphenols and theaflavins are present in prostate tissue of humans and mice after green and black tea consumption. J Nutr 136, 1839–1843, 2006.
   PubMed Web of Science ®Google Scholar
• Jian L, Lee AH, and Binns CW: Tea and lycopene protect against prostate cancer. Asia Pac J Clin Nutr 16(Suppl 1), 453–457, 2007.
   PubMed Web of Science ®Google Scholar
• Jian L, Xie LP, Lee AH, and Binns CW: Protective effect of green tea against prostate cancer: A case-control study in southeast China. Int J Cancer 108, 130–135, 2004. doi: 10.1002/ijc.11550
   PubMed Web of Science ®Google Scholar
• McLarty J, Bigelow RL, Smith M, Elmajian D, Ankem M, et al.: Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro. Cancer Prev Res (Phila) 2, 673–682, 2009. doi: 10.1158/1940-6207.capr-08-0167
   PubMed Web of Science ®Google Scholar
• Jatoi A, Ellison N, Burch PA, Sloan JA, Dakhil SR, et al.: A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma. Cancer 97, 1442–1446, 2003. doi: 10.1002/cncr.11200
   PubMed Web of Science ®Google Scholar
• Montague J, Butler L, Wu A, Genkinger J, Koh W-P, et al.: Green and black tea intake in relation to prostate cancer risk among Singapore Chinese. Cancer Causes Control 23, 1635–1641, 2012. doi: 10.1007/s10552-012-0041-8
   PubMed Web of Science ®Google Scholar
• Berroukche A, Bendahmane M, and Kandouci BA: Association of diet with the risk of prostate cancer in Western Algeria. Oncologie 14, 674–678, 2012.
   Web of Science ®Google Scholar
• Kikuchi N, Ohmori K, Shimazu T, Nakaya N, Kuriyama S, et al.: No association between green tea and prostate cancer risk in Japanese men: the Ohsaki Cohort Study. Br J Cancer 95, 371–373, 2006.
   PubMed Web of Science ®Google Scholar
• Sonoda T, Nagata Y, Mori M, Miyanaga N, Takashima N, et al.: A case-control study of diet and prostate cancer in Japan: possible protective effect of traditional Japanese diet. Cancer Sci 95, 238–242, 2004. doi: 10.1111/j.1349-7006.2004.tb02209.x
   PubMed Web of Science ®Google Scholar
• Allen NE, Sauvaget C, Roddam AW, Appleby P, Nagano J, et al.: A prospective study of diet and prostate cancer in Japanese men. Cancer Causes Control 15, 911–920, 2004. doi: 10.2307/3553600
   PubMed Web of Science ®Google Scholar
• Severson RK, Nomura AMY, Grove JS, and Stemmermann GN: A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res 49, 1857–1860, 1989.
   PubMed Web of Science ®Google Scholar
• Kumar NB, Pow-Sang J, Egan KM, Spiess PE, Dickinson S, et al.: Randomized, placebo-controlled trial of green tea catechins for prostate cancer prevention. Cancer Prev Res 8, 879–887, 2015. doi: 10.1158/1940-6207.capr-14-0324
   PubMed Web of Science ®Google Scholar
• Li ML, Lin J, Hou JG, Xu L, Cui XG, et al.: Environmental and psycho-social factors related to prostate cancer risk in the Chinese population: a case-control study. Biomed Environ Sci 27, 707–717, 2014. doi: 10.3967/bes2014.089
   PubMed Web of Science ®Google Scholar
• Nguyen MM, Ahmann FR, Nagle RB, Hsu CH, Tangrea JA, et al.: Randomized, double-blind, placebo-controlled trial of polyphenon E in prostate cancer patients before prostatectomy: evaluation of potential chemopreventive activities. Cancer Prev Res (Phila) 5, 290–298, 2012. doi: 10.1158/1940-6207.capr-11-0306
   PubMed Web of Science ®Google Scholar
• Kurahashi N, Sasazuki S, Iwasaki M, and Inoue M: Green tea consumption and prostate cancer risk in Japanese men: a prospective study. Am J Epidemiol 167, 71–77, 2008.
   PubMed Web of Science ®Google Scholar
• Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, et al.: Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res 66, 1234–1240, 2006. doi: 10.1158/0008-5472.can-05-1145
   PubMed Web of Science ®Google Scholar
• Choan E, Segal R, Jonker D, Malone S, Reaume N, et al.: A prospective clinical trial of green tea for hormone refractory prostate cancer: an evaluation of the complementary/alternative therapy approach. Urol Oncol 23, 108–113, 2005. doi: 10.1016/j.urolonc.2004.10.008
   PubMed Web of Science ®Google Scholar
• Fritz H, Seely D, Kennedy DA, Fernandes R, Cooley K, et al.: Green tea and lung cancer: A systematic review. Integr Cancer Ther 12, 7–24, 2013.
   PubMed Web of Science ®Google Scholar
• Khan N, Adhami VM, and Mukhtar H: Review: green tea polyphenols in chemoprevention of prostate cancer: preclinical and clinical studies. Nutr Cancer 61, 836–841, 2009. doi: 10.1080/01635580903285056
   PubMed Web of Science ®Google Scholar
• Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, et al.: GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 International Agency for Research on Cancer: Lyon, France, 2013.
   Google Scholar
• Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, et al.: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136, E359–E386, 2015. doi: 10.1002/ijc.29210
   PubMed Web of Science ®Google Scholar
• Ito K: Prostate cancer in Asian men. Nat Rev Urol 11, 197–212, 2014. doi: 10.1038/nrurol.2014.42
   PubMed Web of Science ®Google Scholar
• Cabrera C, Artacho R, Giménez R: Beneficial effects of green tea—a review. J Am College Nutr 25, 79–99, 2006. doi: 10.1080/07315724.2006.10719518
   PubMed Web of Science ®Google Scholar
• Paolini M, Abdel-Rahman SZ, Sapone A, Pedulli GF, Perocco P, et al.: β-Carotene: a cancer chemopreventive agent or a co-carcinogen? Mutat Res/Rev Mutat Res 543, 195–200, 2003. doi: http://dx.doi.org/10.1016/S1383-5742(03)00002-4
   PubMed Web of Science ®Google Scholar
• Vance TM, Su J, Fontham ETH, Koo SI, and Chun OK: Dietary antioxidants and prostate cancer: a review. Nutr Cancer 65, 10.1080/01635581.2013.806672, 2013. doi: 10.1080/01635581.2013.806672
   PubMed Web of Science ®Google Scholar
• Chacko SM, Thambi PT, Kuttan R, and Nishigaki I: Beneficial effects of green tea: a literature review. Chin Med 5, 13, 2010. doi: 10.1186/1749-8546-5-13
   PubMedGoogle Scholar
• Henning S, Wang P, Carpenter C, Aronson W, and Heber D: Effects of brewed green and black tea on inflammation, apoptosis and oxidation in men with prostate cancer. FASEB J 28, Supplement 136.3, 2014.
   Web of Science ®Google Scholar
• Lane A, Avery K, Donovan J, Macefield R, Gillatt D, et al.: Prodiet: The feasibility of a randomised controlled trial of dietary interventions for men at elevated risk of prostate cancer. Urology 80, S31–S32, 2012.
   Web of Science ®Google Scholar
• Wu Y J, Liang C H, Zhou F J, Gao X, Chen L W, et al.: A case-control study of environmental and genetic factors and prostate cancer in Guangdong (Chinese). Chin J Prev Med 43, 581–585, 2009.
   Google Scholar
• Henning SM, Wang P, Carpenter CL, and Heber D: Epigenetic effects of green tea polyphenols in cancer. Epigenomics 5, 729–741, 2013. doi: 10.2217/epi.13.57
   PubMed Web of Science ®Google Scholar
• Lin IH, Ho M-L, Chen H-Y, Lee H-S, Huang C-C, et al.: Smoking, green tea consumption, genetic polymorphisms in the insulin-like growth factors and lung cancer risk. PLoS ONE 7, e30951, 2012. doi: 10.1371/journal.pone.0030951
   PubMed Web of Science ®Google Scholar